TY - JOUR
T1 - Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
AU - Huang, Andy
AU - Brennan, Kathleen
AU - Azziz, Ricardo
N1 - Funding Information:
Supported in part by National Institutes of Health grants R01-HD29364 and K24-HD01346-01, and the Helping Hand of Los Angeles, Inc.
PY - 2010/4
Y1 - 2010/4
N2 - Objective: To determine the prevalence of elevated total and free T, and DHEAS, alone and in combination, in patients with polycystic ovary syndrome (PCOS). Design: Cross-sectional analysis. Setting: Tertiary care academic medical center. Patient(s): Seven hundred twenty patients diagnosed with PCOS according to the National Institutes of Health 1990 criteria. Intervention(s): History, physical examination, and blood sampling. Main Outcome Measure(s): Hyperandrogenemia, defined as at least one androgen value above the 95th percentile of 98 healthy control women (i.e., total T >88 ng/dL, free T >0.75 ng/dL, and DHEAS >2,750 ng/mL). Result(s): A total of 716 subjects with PCOS were included. The overall prevalence of hyperandrogenemia in PCOS was 75.3%. Supranormal levels of free T were present in 57.6%, of total T in 33.0%, and of DHEAS in 32.7% of patients with PCOS. When assessing the prevalence of two abnormal values, the prevalence of simultaneously elevated androgens was lowest with total T and DHEAS (1.7%) and highest with total T and free T (20.4%). Altogether, simultaneous elevations in all three markers were found in 8.7% of subjects with PCOS. Conclusion(s): Approximately three-fourths of patients with PCOS diagnosed by the National Institutes of Health 1990 criteria have evidence of hyperandrogenemia; the single most predictive assay was the measurement of free T with ∼60% of patients demonstrating supranormal levels.
AB - Objective: To determine the prevalence of elevated total and free T, and DHEAS, alone and in combination, in patients with polycystic ovary syndrome (PCOS). Design: Cross-sectional analysis. Setting: Tertiary care academic medical center. Patient(s): Seven hundred twenty patients diagnosed with PCOS according to the National Institutes of Health 1990 criteria. Intervention(s): History, physical examination, and blood sampling. Main Outcome Measure(s): Hyperandrogenemia, defined as at least one androgen value above the 95th percentile of 98 healthy control women (i.e., total T >88 ng/dL, free T >0.75 ng/dL, and DHEAS >2,750 ng/mL). Result(s): A total of 716 subjects with PCOS were included. The overall prevalence of hyperandrogenemia in PCOS was 75.3%. Supranormal levels of free T were present in 57.6%, of total T in 33.0%, and of DHEAS in 32.7% of patients with PCOS. When assessing the prevalence of two abnormal values, the prevalence of simultaneously elevated androgens was lowest with total T and DHEAS (1.7%) and highest with total T and free T (20.4%). Altogether, simultaneous elevations in all three markers were found in 8.7% of subjects with PCOS. Conclusion(s): Approximately three-fourths of patients with PCOS diagnosed by the National Institutes of Health 1990 criteria have evidence of hyperandrogenemia; the single most predictive assay was the measurement of free T with ∼60% of patients demonstrating supranormal levels.
KW - Polycystic ovary syndrome
KW - dehydroepiandrosterone sulfate
KW - free testosterone
KW - hyperandrogenemia
KW - total testosterone
UR - http://www.scopus.com/inward/record.url?scp=77949912770&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77949912770&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2008.12.138
DO - 10.1016/j.fertnstert.2008.12.138
M3 - Article
C2 - 19249030
AN - SCOPUS:77949912770
SN - 0015-0282
VL - 93
SP - 1938
EP - 1941
JO - Fertility and sterility
JF - Fertility and sterility
IS - 6
ER -